FT-2109
N/A
Report date: 2026/04/22 20:01:10
NME
Base Information
Drug NameFT-2109
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[11]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[14]
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesForward Therapeutics Inc
China Registration ClassN/A
Develop Information
Active CompaniesForward Therapeutics IncPfizer Inc
Inactive CompaniesN/A
Active Indications +[9]
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A